Selected research
Industry Research
Surface Protein gp120 Industry Research Report 2026
Market perspective
The global Surface Protein gp120 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Surface Protein gp120 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Surface Protein gp120 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Surface Protein gp120 include Sanofi Pasteur SA, GlaxoSmithKline Plc, ViiV Healthcare Limited, United Biomedical, Inc., TeneoBio Inc and Osel, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Surface Protein gp120 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Surface Protein gp120 Market by Company
Sanofi Pasteur SA
GlaxoSmithKline Plc
ViiV Healthcare Limited
United Biomedical, Inc.
TeneoBio Inc
Osel, Inc.
Surface Protein gp120 Segment by Type
BMD-104
DS-003
HNG-156
M-48U1
Others
Surface Protein gp120 Segment by Application
Hospital
Clinic
Others
Surface Protein gp120 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surface Protein gp120 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Surface Protein gp120 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surface Protein gp120.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Surface Protein gp120 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Surface Protein gp120 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Surface Protein gp120 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- BMD-104
- DS-003
- HNG-156
- M-48U1
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Sanofi Pasteur SA
- GlaxoSmithKline Plc
- ViiV Healthcare Limited
- United Biomedical, Inc.
- TeneoBio Inc
- Osel, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Surface Protein gp120 Market Size (2021-2032)
- 2.2.2 Global Surface Protein gp120 Sales (2021-2032)
- 2.2.3 Global Surface Protein gp120 Market Average Price (2021-2032)
- 2.3 Surface Protein gp120 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 BMD-104
- 2.3.3 DS-003
- 2.3.4 HNG-156
- 2.3.5 M-48U1
- 2.3.6 Others
- 2.4 Surface Protein gp120 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Surface Protein gp120 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Surface Protein gp120 Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Surface Protein gp120 Revenue of Manufacturers (2021-2026)
- 3.4 Global Surface Protein gp120 Average Price by Manufacturers (2021-2026)
- 3.5 Global Surface Protein gp120 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Surface Protein gp120, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Surface Protein gp120, Product Type & Application
- 3.8 Global Manufacturers of Surface Protein gp120, Established Date
- 3.9 Global Surface Protein gp120 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi Pasteur SA
- 4.1.1 Sanofi Pasteur SA Company Information
- 4.1.2 Sanofi Pasteur SA Business Overview
- 4.1.3 Sanofi Pasteur SA Surface Protein gp120 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Pasteur SA Surface Protein gp120 Product Portfolio
- 4.1.5 Sanofi Pasteur SA Recent Developments
- 4.2 GlaxoSmithKline Plc
- 4.2.1 GlaxoSmithKline Plc Company Information
- 4.2.2 GlaxoSmithKline Plc Business Overview
- 4.2.3 GlaxoSmithKline Plc Surface Protein gp120 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GlaxoSmithKline Plc Surface Protein gp120 Product Portfolio
- 4.2.5 GlaxoSmithKline Plc Recent Developments
- 4.3 ViiV Healthcare Limited
- 4.3.1 ViiV Healthcare Limited Company Information
- 4.3.2 ViiV Healthcare Limited Business Overview
- 4.3.3 ViiV Healthcare Limited Surface Protein gp120 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ViiV Healthcare Limited Surface Protein gp120 Product Portfolio
- 4.3.5 ViiV Healthcare Limited Recent Developments
- 4.4 United Biomedical, Inc.
- 4.4.1 United Biomedical, Inc. Company Information
- 4.4.2 United Biomedical, Inc. Business Overview
- 4.4.3 United Biomedical, Inc. Surface Protein gp120 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 United Biomedical, Inc. Surface Protein gp120 Product Portfolio
- 4.4.5 United Biomedical, Inc. Recent Developments
- 4.5 TeneoBio Inc
- 4.5.1 TeneoBio Inc Company Information
- 4.5.2 TeneoBio Inc Business Overview
- 4.5.3 TeneoBio Inc Surface Protein gp120 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TeneoBio Inc Surface Protein gp120 Product Portfolio
- 4.5.5 TeneoBio Inc Recent Developments
- 4.6 Osel, Inc.
- 4.6.1 Osel, Inc. Company Information
- 4.6.2 Osel, Inc. Business Overview
- 4.6.3 Osel, Inc. Surface Protein gp120 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Osel, Inc. Surface Protein gp120 Product Portfolio
- 4.6.5 Osel, Inc. Recent Developments
5 Global Surface Protein gp120 Market Scenario by Region
- 5.1 Global Surface Protein gp120 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Surface Protein gp120 Sales by Region: 2021-2032
- 5.2.1 Global Surface Protein gp120 Sales by Region: 2021-2026
- 5.2.2 Global Surface Protein gp120 Sales by Region: 2027-2032
- 5.3 Global Surface Protein gp120 Revenue by Region: 2021-2032
- 5.3.1 Global Surface Protein gp120 Revenue by Region: 2021-2026
- 5.3.2 Global Surface Protein gp120 Revenue by Region: 2027-2032
- 5.4 North America Surface Protein gp120 Market Facts & Figures by Country
- 5.4.1 North America Surface Protein gp120 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Surface Protein gp120 Sales by Country (2021-2032)
- 5.4.3 North America Surface Protein gp120 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Surface Protein gp120 Market Facts & Figures by Country
- 5.5.1 Europe Surface Protein gp120 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Surface Protein gp120 Sales by Country (2021-2032)
- 5.5.3 Europe Surface Protein gp120 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Surface Protein gp120 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Surface Protein gp120 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Surface Protein gp120 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Surface Protein gp120 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Surface Protein gp120 Market Facts & Figures by Country
- 5.7.1 South America Surface Protein gp120 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Surface Protein gp120 Sales by Country (2021-2032)
- 5.7.3 South America Surface Protein gp120 Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Surface Protein gp120 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Surface Protein gp120 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Surface Protein gp120 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Surface Protein gp120 Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Surface Protein gp120 Sales by Type (2021-2032)
- 6.1.1 Global Surface Protein gp120 Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Surface Protein gp120 Sales Market Share by Type (2021-2032)
- 6.2 Global Surface Protein gp120 Revenue by Type (2021-2032)
- 6.2.1 Global Surface Protein gp120 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Surface Protein gp120 Revenue Market Share by Type (2021-2032)
- 6.3 Global Surface Protein gp120 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Surface Protein gp120 Sales by Application (2021-2032)
- 7.1.1 Global Surface Protein gp120 Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Surface Protein gp120 Sales Market Share by Application (2021-2032)
- 7.2 Global Surface Protein gp120 Revenue by Application (2021-2032)
- 7.2.1 Global Surface Protein gp120 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Surface Protein gp120 Revenue Market Share by Application (2021-2032)
- 7.3 Global Surface Protein gp120 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Surface Protein gp120 Value Chain Analysis
- 8.1.1 Surface Protein gp120 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Surface Protein gp120 Production Mode & Process
- 8.2 Surface Protein gp120 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Surface Protein gp120 Distributors
- 8.2.3 Surface Protein gp120 Customers
9 Global Surface Protein gp120 Analyzing Market Dynamics
- 9.1 Surface Protein gp120 Industry Trends
- 9.2 Surface Protein gp120 Industry Drivers
- 9.3 Surface Protein gp120 Industry Opportunities and Challenges
- 9.4 Surface Protein gp120 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst